|Bid||0.5000 x 1000|
|Ask||1.2500 x 11000|
|Day's Range||0.9600 - 1.0400|
|52 Week Range||0.7800 - 5.5900|
|PE Ratio (TTM)||-0.43|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.50|
Investors need to pay close attention to Aeterna Zentaris (AEZS) stock based on the movements in the options market lately.
Aeterna Zentaris Inc. today announced that the Company's President and Chief Executive Officer, David Dodd, will present a corporate overview at the 2017 Marcum MicroCap Conference on Friday, June 16, 2017 at 9:30 a.m.
Categories: Yahoo FinanceGet free summary analysis Æterna Zentaris, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Æterna Zentaris, Inc. – Spectrum Pharmaceuticals, Inc., Keryx Biopharmaceuticals, Inc., Bristol-Myers Squibb Company, Halozyme Therapeutics, Inc. and Novartis AG Sponsored ADR (SPPI-US, KERX-US, BMY-US, HALO-US and NVS-US) that ... Read more (Read more...)